Related Experiment Video
Updated: Jul 1, 2026

Methodology for the Efficient Generation of Fluorescently Tagged Vaccinia Virus Proteins
Published on: January 17, 2014
An integrated structural and immunoinformatic approach to design a multi-epitope based vaccine against the
Sthitaprajna Sahoo1, Hak-Kyo Lee2,3, Donghyun Shin4
1Department of Agricultural Convergence Technology, Jeonbuk National University, Jeonju, 54896, Republic of Korea.
Abstract:
The Foot-and-mouth disease virus (FMDV) is highly contagious, affecting cloven-hoofed animals and causing significant economic losses to the livestock industry. Its high genetic variability complicates vaccine development, necessitating frequent updates to traditional inactivated vaccines. Multi-epitope-based vaccines (MEBVs) offer a promising alternative by incorporating immunogenic epitopes to elicit robust humoral and cell-mediated immune responses, thereby providing broader protection against diverse FMDV strains. Using in silico approaches, we designed a novel FMDV-targeting MBEV specifically tailored to the BoLA alleles to ensure optimal epitope selection for cattle. The MEBV included non-toxic, antigenic, and non-allergenic epitopes combined with β-defensin 3 adjuvants, PADRE sequences, and linkers to enhance immunogenicity and stability. Molecular docking and dynamics simulations confirmed strong binding affinity and stable interactions with TLR3 and TLR7, and immune simulation analysis revealed notable increases in B-cell and T-cell populations, cytokines, and macrophages, with sustained levels of IFN-γ and IL-2. Codon optimization for Escherichia coli K12 enhanced expression, and in silico restriction cloning demonstrated its scalability for production. Our findings suggest that the MEBV design is a cost-effective and efficient approach to combat FMDV. While experimental validation is required, the in silico results also highlight its potential to trigger protective immune responses and address the limitations of traditional vaccines.
More Related Videos
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
Related Concept Videos
Viral Structure
Cross-reactivity